Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Runben Biotechnology (603193.SS)
CNY19.24
+0.79 (+4.28%)
CN SHH Consumer Defensive Household & Personal Products
Address
No. 3, Xinzhuang 5th Road 510627
Guangzhou, CN
Guangzhou, CN
CEO
Guiqin Zhao
Website
runben.com
IPO
2023-10-17
ISIN CNE100006DK5
Description
Runben Biotechnology Co., Ltd. focuses on the creation, production, and distribution of mosquito repellent solutions, infant care items, and essential oil products. The company primarily sells its offerings through digital sales channels. Established in 2013, Runben Biotechnology is headquartered in Guangzhou, China, and functions as a division of Guangzhou Zhuofan Investment Holding Co., Ltd.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY19.24
+0.79 (+4.28%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
0.31
Float Shares
404.59M
Free Float %
100.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.52% | -4.62% | -14.86% | -5.75% | -12.75% | -8.75% | -43.16% | +27.22% | +27.22% | +27.22% | +27.22% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
19.24
DCF (Unlevered)
17.18
-10.7%
DCF (Levered)
15.97
-17.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | +2 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
36.27
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
★ Strong MOAT
-
Revenue growth Household & Personal Products: +3.3%+17.2% ★ Q1'26: +11.3% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+5.4% Q1'26: +18.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+18.2% Q1'26: -13.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+23.5% ★ Q1'26: +18.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+30.1% ★ Q1'26: +16.0% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-0.6% ★ Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.00× ★ Q1'26: 0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
1.03B
est: 1.07B (-3.8%)
|
1.32B
est: 1.32B (-0.1%)
|
1.54B
est: 1.55B (-0.5%)
|
1.87B
1.86B – 1.88B
+20.6% YoY
|
2.22B
2.19B – 2.23B
+18.5% YoY
|
2.60B
2.57B – 2.61B
+17.1% YoY
|
| EBITDA |
288.12M
est: 287.56M (+0.2%)
|
371.76M
est: 341.07M (+9.0%)
|
384.35M
est: 401.21M (-4.2%)
|
483.94M
480.99M – 485.94M
+20.6% YoY
|
573.65M
566.05M – 577.58M
+18.5% YoY
|
671.58M
664.89M – 675.35M
+17.1% YoY
|
| EBIT |
268.28M
est: 266.85M (+0.5%)
|
352.14M
est: 324.95M (+8.4%)
|
362.33M
est: 382.25M (-5.2%)
|
461.07M
458.26M – 462.98M
+20.6% YoY
|
546.55M
539.31M – 550.29M
+18.5% YoY
|
639.85M
633.47M – 643.43M
+17.1% YoY
|
| Net Income |
226.03M
est: 223.67M (+1.1%)
|
300.16M
est: 307.45M (-2.4%)
|
314.50M
est: 314.50M (+0.0%)
|
377.33M
372.44M – 380.08M
+20.0% YoY
|
446.22M
440.44M – 449.47M
+18.3% YoY
|
521.24M
514.48M – 525.03M
+16.8% YoY
|
| SGA |
301.68M
est: 254.43M (+18.6%)
|
411.86M
est: 383.50M (+7.4%)
|
434.61M
est: 451.13M (-3.7%)
|
544.15M
540.83M – 546.39M
+20.6% YoY
|
645.02M
636.48M – 649.44M
+18.5% YoY
|
755.14M
747.61M – 759.37M
+17.1% YoY
|
| EPS |
0.64
est: 0.55 (+16.1%)
|
0.74
est: 0.76 (-3.0%)
|
0.78
est: 0.78 (+0.0%)
|
0.94
0.92 – 0.94
+20.0% YoY
|
1.11
1.09 – 1.11
+18.3% YoY
|
1.29
1.28 – 1.30
+16.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
127.33M
OE per share TTM
0.31
Owner's Yield
1.42%
Maintenance CapEx ratio
62.26%
Maint CapEx / Avg PPE
24.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck - China New Economy ETF CNEW.AX | 0.68% | 480.8K | 0.95% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
393.4K
Shares Outstanding
404.59M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guiqin Zhao | GM & Chairman of the Board | — | male |
| Songjuan Bao | Deputy GM & Vice Chairman | — | female |
| Weibin Wu | Financial Director & Secretary to the Board | — | male |
| Yanjuan Ye | Head of Accounting | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603193.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
